Vanda Pharmaceuticals (VNDA) Raw Materials (2014 - 2015)
Vanda Pharmaceuticals (VNDA) posted Raw Materials of $128000.0 for Q3 2015, little changed sequentially from $128000.0 in Q2 2015, and down 39.91% YoY from $213000.0 in Q3 2014.
Powered by 
Analysis
Vanda Pharmaceuticals (VNDA) Raw Materials (2014 - 2015) Analysis & Trends
Vanda Pharmaceuticals has reported Raw Materials for 2 years, with the latest figure at $128000.0 in Q3 2015.
- Quarterly Raw Materials fell 39.91% year-over-year to $128000.0 in Q3 2015, while the trailing twelve-month figure through Sep 2015 was $128000.0 (down 39.91% YoY) and the FY2014 annual result came in at $198000.0, changed N/A from the prior year.
- Raw Materials steadied at $128000.0 in Q3 2015 per VNDA's latest filing, from $128000.0 in the prior quarter.
- Over five years, Raw Materials peaked at $213000.0 in Q3 2014 and troughed at $128000.0 in Q2 2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Vanda Pharmaceuticals | 327.03 Mn | 157.00 Mn | 46.97 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2015 | 128,000.00 |
| Jun 30, 2015 | 128,000.00 |
| Mar 31, 2015 | 162,000.00 |
| Dec 31, 2014 | 198,000.00 |
| Sep 30, 2014 | 213,000.00 |
| Jun 30, 2014 | 145,000.00 |
| Mar 31, 2014 | 143,000.00 |